Matches in Nanopublications for { ?s ?p "[Eighty-two percent (14 of 17) of Stage III/IV breast ductal carcinomas expressed beta synuclein, gamma synuclein, or both simultaneously.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP284084.RAeDu7OCTfxeuTXEyxNH0G9GcVyq3wtV9oLJ39H5V5-fk130_assertion description "[Eighty-two percent (14 of 17) of Stage III/IV breast ductal carcinomas expressed beta synuclein, gamma synuclein, or both simultaneously.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP284084.RAeDu7OCTfxeuTXEyxNH0G9GcVyq3wtV9oLJ39H5V5-fk130_provenance.
- assertion description "[Eighty-two percent (14 of 17) of Stage III/IV breast ductal carcinomas expressed beta synuclein, gamma synuclein, or both simultaneously.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP704703.RArEXCBWEC2Ihn62clGqgNmrHugB539CNROqmn50dd2zc130_assertion description "[Eighty-two percent (14 of 17) of Stage III/IV breast ductal carcinomas expressed beta synuclein, gamma synuclein, or both simultaneously.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP704703.RArEXCBWEC2Ihn62clGqgNmrHugB539CNROqmn50dd2zc130_provenance.